Global RNA Synthesis Supply, Demand and Key Producers, 2026-2032
The global RNA Synthesis market size is expected to reach $ 6619 million by 2032, rising at a market growth of 12.1% CAGR during the forecast period (2026-2032).
RNA synthesis refers to the products and services provided by suppliers, based on customer-specified RNA sequences, structural modifications, lengths, purity, quality grades, and delivery specifications. These processes include chemical solid-phase phosphorous acid synthesis, liquid-phase/enzymatic ligation, in vitro transcription, capping, tailing, purification, analytical detection, and GMP quality control. The synthesis produces ordinary RNA, modified RNA, RNA oligonucleotides, siRNA, miRNA, sgRNA, crRNA, tracrRNA, mRNA, saRNA, circRNA, RNA/DNA chimeras, RNA aptamers, and related RNA-based drug raw materials.
From a demand structure perspective, the growth in RNA synthesis comes from two directions: first, the routine demand for short-chain, modified, and high-purity RNA oligos from research and diagnostics; and second, the incremental demand from the therapeutic end for the synergistic development of GMP small nucleic acids, mRNA, saRNA, circRNA, and delivery formulations. The commercialization of RNAi drugs has validated the clinical value of small nucleic acid routes such as siRNA, CRISPR applications are driving demand for sgRNA, crRNA, and long RNA, and mRNA vaccine platforms are promoting upgrades in IVT, capping, purification, dsRNA impurity control, and LNP encapsulation capabilities.
This report studies the global RNA Synthesis demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for RNA Synthesis, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of RNA Synthesis that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global RNA Synthesis total market, 2021-2032, (USD Million)
Global RNA Synthesis total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: RNA Synthesis total market, key domestic companies, and share, (USD Million)
Global RNA Synthesis revenue by player, revenue and market share 2021-2026, (USD Million)
Global RNA Synthesis total market by Type, CAGR, 2021-2032, (USD Million)
Global RNA Synthesis total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global RNA Synthesis market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Danaher, Merck, Agilent Technologies, Nitto Denko, ST Pharm, WuXi AppTec, GenScript Biotech, TriLink, Kaneka, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world RNA Synthesis market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global RNA Synthesis Market, By Region:
1. How big is the global RNA Synthesis market?
2. What is the demand of the global RNA Synthesis market?
3. What is the year over year growth of the global RNA Synthesis market?
4. What is the total value of the global RNA Synthesis market?
5. Who are the Major Players in the global RNA Synthesis market?
6. What are the growth factors driving the market demand?
RNA synthesis refers to the products and services provided by suppliers, based on customer-specified RNA sequences, structural modifications, lengths, purity, quality grades, and delivery specifications. These processes include chemical solid-phase phosphorous acid synthesis, liquid-phase/enzymatic ligation, in vitro transcription, capping, tailing, purification, analytical detection, and GMP quality control. The synthesis produces ordinary RNA, modified RNA, RNA oligonucleotides, siRNA, miRNA, sgRNA, crRNA, tracrRNA, mRNA, saRNA, circRNA, RNA/DNA chimeras, RNA aptamers, and related RNA-based drug raw materials.
From a demand structure perspective, the growth in RNA synthesis comes from two directions: first, the routine demand for short-chain, modified, and high-purity RNA oligos from research and diagnostics; and second, the incremental demand from the therapeutic end for the synergistic development of GMP small nucleic acids, mRNA, saRNA, circRNA, and delivery formulations. The commercialization of RNAi drugs has validated the clinical value of small nucleic acid routes such as siRNA, CRISPR applications are driving demand for sgRNA, crRNA, and long RNA, and mRNA vaccine platforms are promoting upgrades in IVT, capping, purification, dsRNA impurity control, and LNP encapsulation capabilities.
This report studies the global RNA Synthesis demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for RNA Synthesis, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of RNA Synthesis that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global RNA Synthesis total market, 2021-2032, (USD Million)
Global RNA Synthesis total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: RNA Synthesis total market, key domestic companies, and share, (USD Million)
Global RNA Synthesis revenue by player, revenue and market share 2021-2026, (USD Million)
Global RNA Synthesis total market by Type, CAGR, 2021-2032, (USD Million)
Global RNA Synthesis total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global RNA Synthesis market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Danaher, Merck, Agilent Technologies, Nitto Denko, ST Pharm, WuXi AppTec, GenScript Biotech, TriLink, Kaneka, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world RNA Synthesis market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global RNA Synthesis Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Transcription
- RNA Replication
- Coding RNA
- Non-coding RNA
- 20~40 nt/s
- 40~100 nt/s
- ?100 nt/s
- Biomedicine
- Molecular Diagnostics
- Agriculture
- Other
- Thermo Fisher Scientific
- Danaher
- Merck
- Agilent Technologies
- Nitto Denko
- ST Pharm
- WuXi AppTec
- GenScript Biotech
- TriLink
- Kaneka
- BioSpring GmbH
- Bachem Holding AG
- Ajinomoto Bio-Pharma Services
- Eurofins Genomics
- Azenta
- Revvity
- LGC Biosearch Technologies
- Hongene Biotech
- Aldevron
- Lonza Group
- Shanghai Jinsirui Vigorous Biotechnology
- PackGene Biotech
- Vernal Biosciences
- Northern RNA
- MedTide Inc.
- Porton Pharma Solutions
- Microsynth AG
- Eton Bioscience
- Aurigene Pharmaceutical Services
- Synbio Technologies
- biomers.net GmbH
- Hunan Aikerui Bioengineering
- Beijing Abace Biotechnology
1. How big is the global RNA Synthesis market?
2. What is the demand of the global RNA Synthesis market?
3. What is the year over year growth of the global RNA Synthesis market?
4. What is the total value of the global RNA Synthesis market?
5. Who are the Major Players in the global RNA Synthesis market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 RNA Synthesis Introduction
1.2 World RNA Synthesis Market Size & Forecast (2021 & 2025 & 2032)
1.3 World RNA Synthesis Total Market by Region (by Headquarter Location)
1.3.1 World RNA Synthesis Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company RNA Synthesis Revenue (2021-2032)
1.3.3 China Based Company RNA Synthesis Revenue (2021-2032)
1.3.4 Europe Based Company RNA Synthesis Revenue (2021-2032)
1.3.5 Japan Based Company RNA Synthesis Revenue (2021-2032)
1.3.6 South Korea Based Company RNA Synthesis Revenue (2021-2032)
1.3.7 ASEAN Based Company RNA Synthesis Revenue (2021-2032)
1.3.8 India Based Company RNA Synthesis Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 RNA Synthesis Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World RNA Synthesis Consumption Value (2021-2032)
2.2 World RNA Synthesis Consumption Value by Region
2.2.1 World RNA Synthesis Consumption Value by Region (2021-2026)
2.2.2 World RNA Synthesis Consumption Value Forecast by Region (2027-2032)
2.3 United States RNA Synthesis Consumption Value (2021-2032)
2.4 China RNA Synthesis Consumption Value (2021-2032)
2.5 Europe RNA Synthesis Consumption Value (2021-2032)
2.6 Japan RNA Synthesis Consumption Value (2021-2032)
2.7 South Korea RNA Synthesis Consumption Value (2021-2032)
2.8 ASEAN RNA Synthesis Consumption Value (2021-2032)
2.9 India RNA Synthesis Consumption Value (2021-2032)
3 WORLD RNA SYNTHESIS COMPANIES COMPETITIVE ANALYSIS
3.1 World RNA Synthesis Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global RNA Synthesis Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for RNA Synthesis in 2025
3.2.3 Global Concentration Ratios (CR8) for RNA Synthesis in 2025
3.3 RNA Synthesis Company Evaluation Quadrant
3.4 RNA Synthesis Market: Overall Company Footprint Analysis
3.4.1 RNA Synthesis Market: Region Footprint
3.4.2 RNA Synthesis Market: Company Product Type Footprint
3.4.3 RNA Synthesis Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: RNA Synthesis Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: RNA Synthesis Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: RNA Synthesis Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: RNA Synthesis Consumption Value Comparison
4.2.1 United States VS China: RNA Synthesis Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: RNA Synthesis Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based RNA Synthesis Companies and Market Share, 2021-2026
4.3.1 United States Based RNA Synthesis Companies, Headquarters (States, Country)
4.3.2 United States Based Companies RNA Synthesis Revenue, (2021-2026)
4.4 China Based Companies RNA Synthesis Revenue and Market Share, 2021-2026
4.4.1 China Based RNA Synthesis Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies RNA Synthesis Revenue, (2021-2026)
4.5 Rest of World Based RNA Synthesis Companies and Market Share, 2021-2026
4.5.1 Rest of World Based RNA Synthesis Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies RNA Synthesis Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World RNA Synthesis Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Transcription
5.2.2 RNA Replication
5.3 Market Segment by Type
5.3.1 World RNA Synthesis Market Size by Type (2021-2026)
5.3.2 World RNA Synthesis Market Size by Type (2027-2032)
5.3.3 World RNA Synthesis Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY PRODUCT FUNCTION
6.1 World RNA Synthesis Market Size Overview by Product Function: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Product Function
6.2.1 Coding RNA
6.2.2 Non-coding RNA
6.3 Market Segment by Product Function
6.3.1 World RNA Synthesis Market Size by Product Function (2021-2026)
6.3.2 World RNA Synthesis Market Size by Product Function (2027-2032)
6.3.3 World RNA Synthesis Market Size Market Share by Product Function (2027-2032)
7 MARKET ANALYSIS BY SYNTHESIS RATE
7.1 World RNA Synthesis Market Size Overview by Synthesis Rate: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Synthesis Rate
7.2.1 20~40 nt/s
7.2.2 40~100 nt/s
7.2.3 ?100 nt/s
7.3 Market Segment by Synthesis Rate
7.3.1 World RNA Synthesis Market Size by Synthesis Rate (2021-2026)
7.3.2 World RNA Synthesis Market Size by Synthesis Rate (2027-2032)
7.3.3 World RNA Synthesis Market Size Market Share by Synthesis Rate (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World RNA Synthesis Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Biomedicine
8.2.2 Molecular Diagnostics
8.2.3 Agriculture
8.2.4 Other
8.3 Market Segment by Application
8.3.1 World RNA Synthesis Market Size by Application (2021-2026)
8.3.2 World RNA Synthesis Market Size by Application (2027-2032)
8.3.3 World RNA Synthesis Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Thermo Fisher Scientific
9.1.1 Thermo Fisher Scientific Details
9.1.2 Thermo Fisher Scientific Major Business
9.1.3 Thermo Fisher Scientific RNA Synthesis Product and Services
9.1.4 Thermo Fisher Scientific RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Thermo Fisher Scientific Recent Developments/Updates
9.1.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.2 Danaher
9.2.1 Danaher Details
9.2.2 Danaher Major Business
9.2.3 Danaher RNA Synthesis Product and Services
9.2.4 Danaher RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Danaher Recent Developments/Updates
9.2.6 Danaher Competitive Strengths & Weaknesses
9.3 Merck
9.3.1 Merck Details
9.3.2 Merck Major Business
9.3.3 Merck RNA Synthesis Product and Services
9.3.4 Merck RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Merck Recent Developments/Updates
9.3.6 Merck Competitive Strengths & Weaknesses
9.4 Agilent Technologies
9.4.1 Agilent Technologies Details
9.4.2 Agilent Technologies Major Business
9.4.3 Agilent Technologies RNA Synthesis Product and Services
9.4.4 Agilent Technologies RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Agilent Technologies Recent Developments/Updates
9.4.6 Agilent Technologies Competitive Strengths & Weaknesses
9.5 Nitto Denko
9.5.1 Nitto Denko Details
9.5.2 Nitto Denko Major Business
9.5.3 Nitto Denko RNA Synthesis Product and Services
9.5.4 Nitto Denko RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Nitto Denko Recent Developments/Updates
9.5.6 Nitto Denko Competitive Strengths & Weaknesses
9.6 ST Pharm
9.6.1 ST Pharm Details
9.6.2 ST Pharm Major Business
9.6.3 ST Pharm RNA Synthesis Product and Services
9.6.4 ST Pharm RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 ST Pharm Recent Developments/Updates
9.6.6 ST Pharm Competitive Strengths & Weaknesses
9.7 WuXi AppTec
9.7.1 WuXi AppTec Details
9.7.2 WuXi AppTec Major Business
9.7.3 WuXi AppTec RNA Synthesis Product and Services
9.7.4 WuXi AppTec RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 WuXi AppTec Recent Developments/Updates
9.7.6 WuXi AppTec Competitive Strengths & Weaknesses
9.8 GenScript Biotech
9.8.1 GenScript Biotech Details
9.8.2 GenScript Biotech Major Business
9.8.3 GenScript Biotech RNA Synthesis Product and Services
9.8.4 GenScript Biotech RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 GenScript Biotech Recent Developments/Updates
9.8.6 GenScript Biotech Competitive Strengths & Weaknesses
9.9 TriLink
9.9.1 TriLink Details
9.9.2 TriLink Major Business
9.9.3 TriLink RNA Synthesis Product and Services
9.9.4 TriLink RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 TriLink Recent Developments/Updates
9.9.6 TriLink Competitive Strengths & Weaknesses
9.10 Kaneka
9.10.1 Kaneka Details
9.10.2 Kaneka Major Business
9.10.3 Kaneka RNA Synthesis Product and Services
9.10.4 Kaneka RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Kaneka Recent Developments/Updates
9.10.6 Kaneka Competitive Strengths & Weaknesses
9.11 BioSpring GmbH
9.11.1 BioSpring GmbH Details
9.11.2 BioSpring GmbH Major Business
9.11.3 BioSpring GmbH RNA Synthesis Product and Services
9.11.4 BioSpring GmbH RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 BioSpring GmbH Recent Developments/Updates
9.11.6 BioSpring GmbH Competitive Strengths & Weaknesses
9.12 Bachem Holding AG
9.12.1 Bachem Holding AG Details
9.12.2 Bachem Holding AG Major Business
9.12.3 Bachem Holding AG RNA Synthesis Product and Services
9.12.4 Bachem Holding AG RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Bachem Holding AG Recent Developments/Updates
9.12.6 Bachem Holding AG Competitive Strengths & Weaknesses
9.13 Ajinomoto Bio-Pharma Services
9.13.1 Ajinomoto Bio-Pharma Services Details
9.13.2 Ajinomoto Bio-Pharma Services Major Business
9.13.3 Ajinomoto Bio-Pharma Services RNA Synthesis Product and Services
9.13.4 Ajinomoto Bio-Pharma Services RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Ajinomoto Bio-Pharma Services Recent Developments/Updates
9.13.6 Ajinomoto Bio-Pharma Services Competitive Strengths & Weaknesses
9.14 Eurofins Genomics
9.14.1 Eurofins Genomics Details
9.14.2 Eurofins Genomics Major Business
9.14.3 Eurofins Genomics RNA Synthesis Product and Services
9.14.4 Eurofins Genomics RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Eurofins Genomics Recent Developments/Updates
9.14.6 Eurofins Genomics Competitive Strengths & Weaknesses
9.15 Azenta
9.15.1 Azenta Details
9.15.2 Azenta Major Business
9.15.3 Azenta RNA Synthesis Product and Services
9.15.4 Azenta RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Azenta Recent Developments/Updates
9.15.6 Azenta Competitive Strengths & Weaknesses
9.16 Revvity
9.16.1 Revvity Details
9.16.2 Revvity Major Business
9.16.3 Revvity RNA Synthesis Product and Services
9.16.4 Revvity RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Revvity Recent Developments/Updates
9.16.6 Revvity Competitive Strengths & Weaknesses
9.17 LGC Biosearch Technologies
9.17.1 LGC Biosearch Technologies Details
9.17.2 LGC Biosearch Technologies Major Business
9.17.3 LGC Biosearch Technologies RNA Synthesis Product and Services
9.17.4 LGC Biosearch Technologies RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 LGC Biosearch Technologies Recent Developments/Updates
9.17.6 LGC Biosearch Technologies Competitive Strengths & Weaknesses
9.18 Hongene Biotech
9.18.1 Hongene Biotech Details
9.18.2 Hongene Biotech Major Business
9.18.3 Hongene Biotech RNA Synthesis Product and Services
9.18.4 Hongene Biotech RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Hongene Biotech Recent Developments/Updates
9.18.6 Hongene Biotech Competitive Strengths & Weaknesses
9.19 Aldevron
9.19.1 Aldevron Details
9.19.2 Aldevron Major Business
9.19.3 Aldevron RNA Synthesis Product and Services
9.19.4 Aldevron RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Aldevron Recent Developments/Updates
9.19.6 Aldevron Competitive Strengths & Weaknesses
9.20 Lonza Group
9.20.1 Lonza Group Details
9.20.2 Lonza Group Major Business
9.20.3 Lonza Group RNA Synthesis Product and Services
9.20.4 Lonza Group RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 Lonza Group Recent Developments/Updates
9.20.6 Lonza Group Competitive Strengths & Weaknesses
9.21 Shanghai Jinsirui Vigorous Biotechnology
9.21.1 Shanghai Jinsirui Vigorous Biotechnology Details
9.21.2 Shanghai Jinsirui Vigorous Biotechnology Major Business
9.21.3 Shanghai Jinsirui Vigorous Biotechnology RNA Synthesis Product and Services
9.21.4 Shanghai Jinsirui Vigorous Biotechnology RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 Shanghai Jinsirui Vigorous Biotechnology Recent Developments/Updates
9.21.6 Shanghai Jinsirui Vigorous Biotechnology Competitive Strengths & Weaknesses
9.22 PackGene Biotech
9.22.1 PackGene Biotech Details
9.22.2 PackGene Biotech Major Business
9.22.3 PackGene Biotech RNA Synthesis Product and Services
9.22.4 PackGene Biotech RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 PackGene Biotech Recent Developments/Updates
9.22.6 PackGene Biotech Competitive Strengths & Weaknesses
9.23 Vernal Biosciences
9.23.1 Vernal Biosciences Details
9.23.2 Vernal Biosciences Major Business
9.23.3 Vernal Biosciences RNA Synthesis Product and Services
9.23.4 Vernal Biosciences RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 Vernal Biosciences Recent Developments/Updates
9.23.6 Vernal Biosciences Competitive Strengths & Weaknesses
9.24 Northern RNA
9.24.1 Northern RNA Details
9.24.2 Northern RNA Major Business
9.24.3 Northern RNA RNA Synthesis Product and Services
9.24.4 Northern RNA RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 Northern RNA Recent Developments/Updates
9.24.6 Northern RNA Competitive Strengths & Weaknesses
9.25 MedTide Inc.
9.25.1 MedTide Inc. Details
9.25.2 MedTide Inc. Major Business
9.25.3 MedTide Inc. RNA Synthesis Product and Services
9.25.4 MedTide Inc. RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.25.5 MedTide Inc. Recent Developments/Updates
9.25.6 MedTide Inc. Competitive Strengths & Weaknesses
9.26 Porton Pharma Solutions
9.26.1 Porton Pharma Solutions Details
9.26.2 Porton Pharma Solutions Major Business
9.26.3 Porton Pharma Solutions RNA Synthesis Product and Services
9.26.4 Porton Pharma Solutions RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.26.5 Porton Pharma Solutions Recent Developments/Updates
9.26.6 Porton Pharma Solutions Competitive Strengths & Weaknesses
9.27 Microsynth AG
9.27.1 Microsynth AG Details
9.27.2 Microsynth AG Major Business
9.27.3 Microsynth AG RNA Synthesis Product and Services
9.27.4 Microsynth AG RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.27.5 Microsynth AG Recent Developments/Updates
9.27.6 Microsynth AG Competitive Strengths & Weaknesses
9.28 Eton Bioscience
9.28.1 Eton Bioscience Details
9.28.2 Eton Bioscience Major Business
9.28.3 Eton Bioscience RNA Synthesis Product and Services
9.28.4 Eton Bioscience RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.28.5 Eton Bioscience Recent Developments/Updates
9.28.6 Eton Bioscience Competitive Strengths & Weaknesses
9.29 Aurigene Pharmaceutical Services
9.29.1 Aurigene Pharmaceutical Services Details
9.29.2 Aurigene Pharmaceutical Services Major Business
9.29.3 Aurigene Pharmaceutical Services RNA Synthesis Product and Services
9.29.4 Aurigene Pharmaceutical Services RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.29.5 Aurigene Pharmaceutical Services Recent Developments/Updates
9.29.6 Aurigene Pharmaceutical Services Competitive Strengths & Weaknesses
9.30 Synbio Technologies
9.30.1 Synbio Technologies Details
9.30.2 Synbio Technologies Major Business
9.30.3 Synbio Technologies RNA Synthesis Product and Services
9.30.4 Synbio Technologies RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.30.5 Synbio Technologies Recent Developments/Updates
9.30.6 Synbio Technologies Competitive Strengths & Weaknesses
9.31 biomers.net GmbH
9.31.1 biomers.net GmbH Details
9.31.2 biomers.net GmbH Major Business
9.31.3 biomers.net GmbH RNA Synthesis Product and Services
9.31.4 biomers.net GmbH RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.31.5 biomers.net GmbH Recent Developments/Updates
9.31.6 biomers.net GmbH Competitive Strengths & Weaknesses
9.32 Hunan Aikerui Bioengineering
9.32.1 Hunan Aikerui Bioengineering Details
9.32.2 Hunan Aikerui Bioengineering Major Business
9.32.3 Hunan Aikerui Bioengineering RNA Synthesis Product and Services
9.32.4 Hunan Aikerui Bioengineering RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.32.5 Hunan Aikerui Bioengineering Recent Developments/Updates
9.32.6 Hunan Aikerui Bioengineering Competitive Strengths & Weaknesses
9.33 Beijing Abace Biotechnology
9.33.1 Beijing Abace Biotechnology Details
9.33.2 Beijing Abace Biotechnology Major Business
9.33.3 Beijing Abace Biotechnology RNA Synthesis Product and Services
9.33.4 Beijing Abace Biotechnology RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.33.5 Beijing Abace Biotechnology Recent Developments/Updates
9.33.6 Beijing Abace Biotechnology Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 RNA Synthesis Industry Chain
10.2 RNA Synthesis Upstream Analysis
10.3 RNA Synthesis Midstream Analysis
10.4 RNA Synthesis Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 RNA Synthesis Introduction
1.2 World RNA Synthesis Market Size & Forecast (2021 & 2025 & 2032)
1.3 World RNA Synthesis Total Market by Region (by Headquarter Location)
1.3.1 World RNA Synthesis Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company RNA Synthesis Revenue (2021-2032)
1.3.3 China Based Company RNA Synthesis Revenue (2021-2032)
1.3.4 Europe Based Company RNA Synthesis Revenue (2021-2032)
1.3.5 Japan Based Company RNA Synthesis Revenue (2021-2032)
1.3.6 South Korea Based Company RNA Synthesis Revenue (2021-2032)
1.3.7 ASEAN Based Company RNA Synthesis Revenue (2021-2032)
1.3.8 India Based Company RNA Synthesis Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 RNA Synthesis Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World RNA Synthesis Consumption Value (2021-2032)
2.2 World RNA Synthesis Consumption Value by Region
2.2.1 World RNA Synthesis Consumption Value by Region (2021-2026)
2.2.2 World RNA Synthesis Consumption Value Forecast by Region (2027-2032)
2.3 United States RNA Synthesis Consumption Value (2021-2032)
2.4 China RNA Synthesis Consumption Value (2021-2032)
2.5 Europe RNA Synthesis Consumption Value (2021-2032)
2.6 Japan RNA Synthesis Consumption Value (2021-2032)
2.7 South Korea RNA Synthesis Consumption Value (2021-2032)
2.8 ASEAN RNA Synthesis Consumption Value (2021-2032)
2.9 India RNA Synthesis Consumption Value (2021-2032)
3 WORLD RNA SYNTHESIS COMPANIES COMPETITIVE ANALYSIS
3.1 World RNA Synthesis Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global RNA Synthesis Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for RNA Synthesis in 2025
3.2.3 Global Concentration Ratios (CR8) for RNA Synthesis in 2025
3.3 RNA Synthesis Company Evaluation Quadrant
3.4 RNA Synthesis Market: Overall Company Footprint Analysis
3.4.1 RNA Synthesis Market: Region Footprint
3.4.2 RNA Synthesis Market: Company Product Type Footprint
3.4.3 RNA Synthesis Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: RNA Synthesis Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: RNA Synthesis Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: RNA Synthesis Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: RNA Synthesis Consumption Value Comparison
4.2.1 United States VS China: RNA Synthesis Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: RNA Synthesis Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based RNA Synthesis Companies and Market Share, 2021-2026
4.3.1 United States Based RNA Synthesis Companies, Headquarters (States, Country)
4.3.2 United States Based Companies RNA Synthesis Revenue, (2021-2026)
4.4 China Based Companies RNA Synthesis Revenue and Market Share, 2021-2026
4.4.1 China Based RNA Synthesis Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies RNA Synthesis Revenue, (2021-2026)
4.5 Rest of World Based RNA Synthesis Companies and Market Share, 2021-2026
4.5.1 Rest of World Based RNA Synthesis Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies RNA Synthesis Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World RNA Synthesis Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Transcription
5.2.2 RNA Replication
5.3 Market Segment by Type
5.3.1 World RNA Synthesis Market Size by Type (2021-2026)
5.3.2 World RNA Synthesis Market Size by Type (2027-2032)
5.3.3 World RNA Synthesis Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY PRODUCT FUNCTION
6.1 World RNA Synthesis Market Size Overview by Product Function: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Product Function
6.2.1 Coding RNA
6.2.2 Non-coding RNA
6.3 Market Segment by Product Function
6.3.1 World RNA Synthesis Market Size by Product Function (2021-2026)
6.3.2 World RNA Synthesis Market Size by Product Function (2027-2032)
6.3.3 World RNA Synthesis Market Size Market Share by Product Function (2027-2032)
7 MARKET ANALYSIS BY SYNTHESIS RATE
7.1 World RNA Synthesis Market Size Overview by Synthesis Rate: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Synthesis Rate
7.2.1 20~40 nt/s
7.2.2 40~100 nt/s
7.2.3 ?100 nt/s
7.3 Market Segment by Synthesis Rate
7.3.1 World RNA Synthesis Market Size by Synthesis Rate (2021-2026)
7.3.2 World RNA Synthesis Market Size by Synthesis Rate (2027-2032)
7.3.3 World RNA Synthesis Market Size Market Share by Synthesis Rate (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World RNA Synthesis Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Biomedicine
8.2.2 Molecular Diagnostics
8.2.3 Agriculture
8.2.4 Other
8.3 Market Segment by Application
8.3.1 World RNA Synthesis Market Size by Application (2021-2026)
8.3.2 World RNA Synthesis Market Size by Application (2027-2032)
8.3.3 World RNA Synthesis Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Thermo Fisher Scientific
9.1.1 Thermo Fisher Scientific Details
9.1.2 Thermo Fisher Scientific Major Business
9.1.3 Thermo Fisher Scientific RNA Synthesis Product and Services
9.1.4 Thermo Fisher Scientific RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Thermo Fisher Scientific Recent Developments/Updates
9.1.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.2 Danaher
9.2.1 Danaher Details
9.2.2 Danaher Major Business
9.2.3 Danaher RNA Synthesis Product and Services
9.2.4 Danaher RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Danaher Recent Developments/Updates
9.2.6 Danaher Competitive Strengths & Weaknesses
9.3 Merck
9.3.1 Merck Details
9.3.2 Merck Major Business
9.3.3 Merck RNA Synthesis Product and Services
9.3.4 Merck RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Merck Recent Developments/Updates
9.3.6 Merck Competitive Strengths & Weaknesses
9.4 Agilent Technologies
9.4.1 Agilent Technologies Details
9.4.2 Agilent Technologies Major Business
9.4.3 Agilent Technologies RNA Synthesis Product and Services
9.4.4 Agilent Technologies RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Agilent Technologies Recent Developments/Updates
9.4.6 Agilent Technologies Competitive Strengths & Weaknesses
9.5 Nitto Denko
9.5.1 Nitto Denko Details
9.5.2 Nitto Denko Major Business
9.5.3 Nitto Denko RNA Synthesis Product and Services
9.5.4 Nitto Denko RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Nitto Denko Recent Developments/Updates
9.5.6 Nitto Denko Competitive Strengths & Weaknesses
9.6 ST Pharm
9.6.1 ST Pharm Details
9.6.2 ST Pharm Major Business
9.6.3 ST Pharm RNA Synthesis Product and Services
9.6.4 ST Pharm RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 ST Pharm Recent Developments/Updates
9.6.6 ST Pharm Competitive Strengths & Weaknesses
9.7 WuXi AppTec
9.7.1 WuXi AppTec Details
9.7.2 WuXi AppTec Major Business
9.7.3 WuXi AppTec RNA Synthesis Product and Services
9.7.4 WuXi AppTec RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 WuXi AppTec Recent Developments/Updates
9.7.6 WuXi AppTec Competitive Strengths & Weaknesses
9.8 GenScript Biotech
9.8.1 GenScript Biotech Details
9.8.2 GenScript Biotech Major Business
9.8.3 GenScript Biotech RNA Synthesis Product and Services
9.8.4 GenScript Biotech RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 GenScript Biotech Recent Developments/Updates
9.8.6 GenScript Biotech Competitive Strengths & Weaknesses
9.9 TriLink
9.9.1 TriLink Details
9.9.2 TriLink Major Business
9.9.3 TriLink RNA Synthesis Product and Services
9.9.4 TriLink RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 TriLink Recent Developments/Updates
9.9.6 TriLink Competitive Strengths & Weaknesses
9.10 Kaneka
9.10.1 Kaneka Details
9.10.2 Kaneka Major Business
9.10.3 Kaneka RNA Synthesis Product and Services
9.10.4 Kaneka RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Kaneka Recent Developments/Updates
9.10.6 Kaneka Competitive Strengths & Weaknesses
9.11 BioSpring GmbH
9.11.1 BioSpring GmbH Details
9.11.2 BioSpring GmbH Major Business
9.11.3 BioSpring GmbH RNA Synthesis Product and Services
9.11.4 BioSpring GmbH RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 BioSpring GmbH Recent Developments/Updates
9.11.6 BioSpring GmbH Competitive Strengths & Weaknesses
9.12 Bachem Holding AG
9.12.1 Bachem Holding AG Details
9.12.2 Bachem Holding AG Major Business
9.12.3 Bachem Holding AG RNA Synthesis Product and Services
9.12.4 Bachem Holding AG RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Bachem Holding AG Recent Developments/Updates
9.12.6 Bachem Holding AG Competitive Strengths & Weaknesses
9.13 Ajinomoto Bio-Pharma Services
9.13.1 Ajinomoto Bio-Pharma Services Details
9.13.2 Ajinomoto Bio-Pharma Services Major Business
9.13.3 Ajinomoto Bio-Pharma Services RNA Synthesis Product and Services
9.13.4 Ajinomoto Bio-Pharma Services RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Ajinomoto Bio-Pharma Services Recent Developments/Updates
9.13.6 Ajinomoto Bio-Pharma Services Competitive Strengths & Weaknesses
9.14 Eurofins Genomics
9.14.1 Eurofins Genomics Details
9.14.2 Eurofins Genomics Major Business
9.14.3 Eurofins Genomics RNA Synthesis Product and Services
9.14.4 Eurofins Genomics RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Eurofins Genomics Recent Developments/Updates
9.14.6 Eurofins Genomics Competitive Strengths & Weaknesses
9.15 Azenta
9.15.1 Azenta Details
9.15.2 Azenta Major Business
9.15.3 Azenta RNA Synthesis Product and Services
9.15.4 Azenta RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Azenta Recent Developments/Updates
9.15.6 Azenta Competitive Strengths & Weaknesses
9.16 Revvity
9.16.1 Revvity Details
9.16.2 Revvity Major Business
9.16.3 Revvity RNA Synthesis Product and Services
9.16.4 Revvity RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Revvity Recent Developments/Updates
9.16.6 Revvity Competitive Strengths & Weaknesses
9.17 LGC Biosearch Technologies
9.17.1 LGC Biosearch Technologies Details
9.17.2 LGC Biosearch Technologies Major Business
9.17.3 LGC Biosearch Technologies RNA Synthesis Product and Services
9.17.4 LGC Biosearch Technologies RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 LGC Biosearch Technologies Recent Developments/Updates
9.17.6 LGC Biosearch Technologies Competitive Strengths & Weaknesses
9.18 Hongene Biotech
9.18.1 Hongene Biotech Details
9.18.2 Hongene Biotech Major Business
9.18.3 Hongene Biotech RNA Synthesis Product and Services
9.18.4 Hongene Biotech RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Hongene Biotech Recent Developments/Updates
9.18.6 Hongene Biotech Competitive Strengths & Weaknesses
9.19 Aldevron
9.19.1 Aldevron Details
9.19.2 Aldevron Major Business
9.19.3 Aldevron RNA Synthesis Product and Services
9.19.4 Aldevron RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Aldevron Recent Developments/Updates
9.19.6 Aldevron Competitive Strengths & Weaknesses
9.20 Lonza Group
9.20.1 Lonza Group Details
9.20.2 Lonza Group Major Business
9.20.3 Lonza Group RNA Synthesis Product and Services
9.20.4 Lonza Group RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 Lonza Group Recent Developments/Updates
9.20.6 Lonza Group Competitive Strengths & Weaknesses
9.21 Shanghai Jinsirui Vigorous Biotechnology
9.21.1 Shanghai Jinsirui Vigorous Biotechnology Details
9.21.2 Shanghai Jinsirui Vigorous Biotechnology Major Business
9.21.3 Shanghai Jinsirui Vigorous Biotechnology RNA Synthesis Product and Services
9.21.4 Shanghai Jinsirui Vigorous Biotechnology RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 Shanghai Jinsirui Vigorous Biotechnology Recent Developments/Updates
9.21.6 Shanghai Jinsirui Vigorous Biotechnology Competitive Strengths & Weaknesses
9.22 PackGene Biotech
9.22.1 PackGene Biotech Details
9.22.2 PackGene Biotech Major Business
9.22.3 PackGene Biotech RNA Synthesis Product and Services
9.22.4 PackGene Biotech RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 PackGene Biotech Recent Developments/Updates
9.22.6 PackGene Biotech Competitive Strengths & Weaknesses
9.23 Vernal Biosciences
9.23.1 Vernal Biosciences Details
9.23.2 Vernal Biosciences Major Business
9.23.3 Vernal Biosciences RNA Synthesis Product and Services
9.23.4 Vernal Biosciences RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 Vernal Biosciences Recent Developments/Updates
9.23.6 Vernal Biosciences Competitive Strengths & Weaknesses
9.24 Northern RNA
9.24.1 Northern RNA Details
9.24.2 Northern RNA Major Business
9.24.3 Northern RNA RNA Synthesis Product and Services
9.24.4 Northern RNA RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 Northern RNA Recent Developments/Updates
9.24.6 Northern RNA Competitive Strengths & Weaknesses
9.25 MedTide Inc.
9.25.1 MedTide Inc. Details
9.25.2 MedTide Inc. Major Business
9.25.3 MedTide Inc. RNA Synthesis Product and Services
9.25.4 MedTide Inc. RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.25.5 MedTide Inc. Recent Developments/Updates
9.25.6 MedTide Inc. Competitive Strengths & Weaknesses
9.26 Porton Pharma Solutions
9.26.1 Porton Pharma Solutions Details
9.26.2 Porton Pharma Solutions Major Business
9.26.3 Porton Pharma Solutions RNA Synthesis Product and Services
9.26.4 Porton Pharma Solutions RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.26.5 Porton Pharma Solutions Recent Developments/Updates
9.26.6 Porton Pharma Solutions Competitive Strengths & Weaknesses
9.27 Microsynth AG
9.27.1 Microsynth AG Details
9.27.2 Microsynth AG Major Business
9.27.3 Microsynth AG RNA Synthesis Product and Services
9.27.4 Microsynth AG RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.27.5 Microsynth AG Recent Developments/Updates
9.27.6 Microsynth AG Competitive Strengths & Weaknesses
9.28 Eton Bioscience
9.28.1 Eton Bioscience Details
9.28.2 Eton Bioscience Major Business
9.28.3 Eton Bioscience RNA Synthesis Product and Services
9.28.4 Eton Bioscience RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.28.5 Eton Bioscience Recent Developments/Updates
9.28.6 Eton Bioscience Competitive Strengths & Weaknesses
9.29 Aurigene Pharmaceutical Services
9.29.1 Aurigene Pharmaceutical Services Details
9.29.2 Aurigene Pharmaceutical Services Major Business
9.29.3 Aurigene Pharmaceutical Services RNA Synthesis Product and Services
9.29.4 Aurigene Pharmaceutical Services RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.29.5 Aurigene Pharmaceutical Services Recent Developments/Updates
9.29.6 Aurigene Pharmaceutical Services Competitive Strengths & Weaknesses
9.30 Synbio Technologies
9.30.1 Synbio Technologies Details
9.30.2 Synbio Technologies Major Business
9.30.3 Synbio Technologies RNA Synthesis Product and Services
9.30.4 Synbio Technologies RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.30.5 Synbio Technologies Recent Developments/Updates
9.30.6 Synbio Technologies Competitive Strengths & Weaknesses
9.31 biomers.net GmbH
9.31.1 biomers.net GmbH Details
9.31.2 biomers.net GmbH Major Business
9.31.3 biomers.net GmbH RNA Synthesis Product and Services
9.31.4 biomers.net GmbH RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.31.5 biomers.net GmbH Recent Developments/Updates
9.31.6 biomers.net GmbH Competitive Strengths & Weaknesses
9.32 Hunan Aikerui Bioengineering
9.32.1 Hunan Aikerui Bioengineering Details
9.32.2 Hunan Aikerui Bioengineering Major Business
9.32.3 Hunan Aikerui Bioengineering RNA Synthesis Product and Services
9.32.4 Hunan Aikerui Bioengineering RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.32.5 Hunan Aikerui Bioengineering Recent Developments/Updates
9.32.6 Hunan Aikerui Bioengineering Competitive Strengths & Weaknesses
9.33 Beijing Abace Biotechnology
9.33.1 Beijing Abace Biotechnology Details
9.33.2 Beijing Abace Biotechnology Major Business
9.33.3 Beijing Abace Biotechnology RNA Synthesis Product and Services
9.33.4 Beijing Abace Biotechnology RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)
9.33.5 Beijing Abace Biotechnology Recent Developments/Updates
9.33.6 Beijing Abace Biotechnology Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 RNA Synthesis Industry Chain
10.2 RNA Synthesis Upstream Analysis
10.3 RNA Synthesis Midstream Analysis
10.4 RNA Synthesis Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World RNA Synthesis Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World RNA Synthesis Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World RNA Synthesis Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World RNA Synthesis Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World RNA Synthesis Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World RNA Synthesis Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World RNA Synthesis Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World RNA Synthesis Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World RNA Synthesis Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key RNA Synthesis Players in 2025
Table 12. World RNA Synthesis Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global RNA Synthesis Company Evaluation Quadrant
Table 14. Head Office of Key RNA Synthesis Players
Table 15. RNA Synthesis Market: Company Product Type Footprint
Table 16. RNA Synthesis Market: Company Product Application Footprint
Table 17. RNA Synthesis Mergers & Acquisitions Activity
Table 18. United States VS China RNA Synthesis Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China RNA Synthesis Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based RNA Synthesis Companies, Headquarters (States, Country)
Table 21. United States Based Companies RNA Synthesis Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies RNA Synthesis Revenue Market Share (2021-2026)
Table 23. China Based RNA Synthesis Companies, Headquarters (Province, Country)
Table 24. China Based Companies RNA Synthesis Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies RNA Synthesis Revenue Market Share (2021-2026)
Table 26. Rest of World Based RNA Synthesis Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies RNA Synthesis Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies RNA Synthesis Revenue Market Share (2021-2026)
Table 29. World RNA Synthesis Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World RNA Synthesis Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World RNA Synthesis Market Size by Type (2027-2032) & (USD Million)
Table 32. World RNA Synthesis Market Size by Product Function, (USD Million), 2021 & 2025 & 2032
Table 33. World RNA Synthesis Market Size Value by Product Function (2021-2026) & (USD Million)
Table 34. World RNA Synthesis Market Size by Product Function (2027-2032) & (USD Million)
Table 35. World RNA Synthesis Market Size by Synthesis Rate, (USD Million), 2021 & 2025 & 2032
Table 36. World RNA Synthesis Market Size Value by Synthesis Rate (2021-2026) & (USD Million)
Table 37. World RNA Synthesis Market Size by Synthesis Rate (2027-2032) & (USD Million)
Table 38. World RNA Synthesis Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World RNA Synthesis Market Size by Application (2021-2026) & (USD Million)
Table 40. World RNA Synthesis Market Size by Application (2027-2032) & (USD Million)
Table 41. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 42. Thermo Fisher Scientific Major Business
Table 43. Thermo Fisher Scientific RNA Synthesis Product and Services
Table 44. Thermo Fisher Scientific RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Thermo Fisher Scientific Recent Developments/Updates
Table 46. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 47. Danaher Basic Information, Manufacturing Base and Competitors
Table 48. Danaher Major Business
Table 49. Danaher RNA Synthesis Product and Services
Table 50. Danaher RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Danaher Recent Developments/Updates
Table 52. Danaher Competitive Strengths & Weaknesses
Table 53. Merck Basic Information, Manufacturing Base and Competitors
Table 54. Merck Major Business
Table 55. Merck RNA Synthesis Product and Services
Table 56. Merck RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Merck Recent Developments/Updates
Table 58. Merck Competitive Strengths & Weaknesses
Table 59. Agilent Technologies Basic Information, Manufacturing Base and Competitors
Table 60. Agilent Technologies Major Business
Table 61. Agilent Technologies RNA Synthesis Product and Services
Table 62. Agilent Technologies RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Agilent Technologies Recent Developments/Updates
Table 64. Agilent Technologies Competitive Strengths & Weaknesses
Table 65. Nitto Denko Basic Information, Manufacturing Base and Competitors
Table 66. Nitto Denko Major Business
Table 67. Nitto Denko RNA Synthesis Product and Services
Table 68. Nitto Denko RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Nitto Denko Recent Developments/Updates
Table 70. Nitto Denko Competitive Strengths & Weaknesses
Table 71. ST Pharm Basic Information, Manufacturing Base and Competitors
Table 72. ST Pharm Major Business
Table 73. ST Pharm RNA Synthesis Product and Services
Table 74. ST Pharm RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. ST Pharm Recent Developments/Updates
Table 76. ST Pharm Competitive Strengths & Weaknesses
Table 77. WuXi AppTec Basic Information, Manufacturing Base and Competitors
Table 78. WuXi AppTec Major Business
Table 79. WuXi AppTec RNA Synthesis Product and Services
Table 80. WuXi AppTec RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. WuXi AppTec Recent Developments/Updates
Table 82. WuXi AppTec Competitive Strengths & Weaknesses
Table 83. GenScript Biotech Basic Information, Manufacturing Base and Competitors
Table 84. GenScript Biotech Major Business
Table 85. GenScript Biotech RNA Synthesis Product and Services
Table 86. GenScript Biotech RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. GenScript Biotech Recent Developments/Updates
Table 88. GenScript Biotech Competitive Strengths & Weaknesses
Table 89. TriLink Basic Information, Manufacturing Base and Competitors
Table 90. TriLink Major Business
Table 91. TriLink RNA Synthesis Product and Services
Table 92. TriLink RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. TriLink Recent Developments/Updates
Table 94. TriLink Competitive Strengths & Weaknesses
Table 95. Kaneka Basic Information, Manufacturing Base and Competitors
Table 96. Kaneka Major Business
Table 97. Kaneka RNA Synthesis Product and Services
Table 98. Kaneka RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Kaneka Recent Developments/Updates
Table 100. Kaneka Competitive Strengths & Weaknesses
Table 101. BioSpring GmbH Basic Information, Manufacturing Base and Competitors
Table 102. BioSpring GmbH Major Business
Table 103. BioSpring GmbH RNA Synthesis Product and Services
Table 104. BioSpring GmbH RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. BioSpring GmbH Recent Developments/Updates
Table 106. BioSpring GmbH Competitive Strengths & Weaknesses
Table 107. Bachem Holding AG Basic Information, Manufacturing Base and Competitors
Table 108. Bachem Holding AG Major Business
Table 109. Bachem Holding AG RNA Synthesis Product and Services
Table 110. Bachem Holding AG RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Bachem Holding AG Recent Developments/Updates
Table 112. Bachem Holding AG Competitive Strengths & Weaknesses
Table 113. Ajinomoto Bio-Pharma Services Basic Information, Manufacturing Base and Competitors
Table 114. Ajinomoto Bio-Pharma Services Major Business
Table 115. Ajinomoto Bio-Pharma Services RNA Synthesis Product and Services
Table 116. Ajinomoto Bio-Pharma Services RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Ajinomoto Bio-Pharma Services Recent Developments/Updates
Table 118. Ajinomoto Bio-Pharma Services Competitive Strengths & Weaknesses
Table 119. Eurofins Genomics Basic Information, Manufacturing Base and Competitors
Table 120. Eurofins Genomics Major Business
Table 121. Eurofins Genomics RNA Synthesis Product and Services
Table 122. Eurofins Genomics RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Eurofins Genomics Recent Developments/Updates
Table 124. Eurofins Genomics Competitive Strengths & Weaknesses
Table 125. Azenta Basic Information, Manufacturing Base and Competitors
Table 126. Azenta Major Business
Table 127. Azenta RNA Synthesis Product and Services
Table 128. Azenta RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Azenta Recent Developments/Updates
Table 130. Azenta Competitive Strengths & Weaknesses
Table 131. Revvity Basic Information, Manufacturing Base and Competitors
Table 132. Revvity Major Business
Table 133. Revvity RNA Synthesis Product and Services
Table 134. Revvity RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Revvity Recent Developments/Updates
Table 136. Revvity Competitive Strengths & Weaknesses
Table 137. LGC Biosearch Technologies Basic Information, Manufacturing Base and Competitors
Table 138. LGC Biosearch Technologies Major Business
Table 139. LGC Biosearch Technologies RNA Synthesis Product and Services
Table 140. LGC Biosearch Technologies RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. LGC Biosearch Technologies Recent Developments/Updates
Table 142. LGC Biosearch Technologies Competitive Strengths & Weaknesses
Table 143. Hongene Biotech Basic Information, Manufacturing Base and Competitors
Table 144. Hongene Biotech Major Business
Table 145. Hongene Biotech RNA Synthesis Product and Services
Table 146. Hongene Biotech RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Hongene Biotech Recent Developments/Updates
Table 148. Hongene Biotech Competitive Strengths & Weaknesses
Table 149. Aldevron Basic Information, Manufacturing Base and Competitors
Table 150. Aldevron Major Business
Table 151. Aldevron RNA Synthesis Product and Services
Table 152. Aldevron RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Aldevron Recent Developments/Updates
Table 154. Aldevron Competitive Strengths & Weaknesses
Table 155. Lonza Group Basic Information, Manufacturing Base and Competitors
Table 156. Lonza Group Major Business
Table 157. Lonza Group RNA Synthesis Product and Services
Table 158. Lonza Group RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. Lonza Group Recent Developments/Updates
Table 160. Lonza Group Competitive Strengths & Weaknesses
Table 161. Shanghai Jinsirui Vigorous Biotechnology Basic Information, Manufacturing Base and Competitors
Table 162. Shanghai Jinsirui Vigorous Biotechnology Major Business
Table 163. Shanghai Jinsirui Vigorous Biotechnology RNA Synthesis Product and Services
Table 164. Shanghai Jinsirui Vigorous Biotechnology RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. Shanghai Jinsirui Vigorous Biotechnology Recent Developments/Updates
Table 166. Shanghai Jinsirui Vigorous Biotechnology Competitive Strengths & Weaknesses
Table 167. PackGene Biotech Basic Information, Manufacturing Base and Competitors
Table 168. PackGene Biotech Major Business
Table 169. PackGene Biotech RNA Synthesis Product and Services
Table 170. PackGene Biotech RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. PackGene Biotech Recent Developments/Updates
Table 172. PackGene Biotech Competitive Strengths & Weaknesses
Table 173. Vernal Biosciences Basic Information, Manufacturing Base and Competitors
Table 174. Vernal Biosciences Major Business
Table 175. Vernal Biosciences RNA Synthesis Product and Services
Table 176. Vernal Biosciences RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. Vernal Biosciences Recent Developments/Updates
Table 178. Vernal Biosciences Competitive Strengths & Weaknesses
Table 179. Northern RNA Basic Information, Manufacturing Base and Competitors
Table 180. Northern RNA Major Business
Table 181. Northern RNA RNA Synthesis Product and Services
Table 182. Northern RNA RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. Northern RNA Recent Developments/Updates
Table 184. Northern RNA Competitive Strengths & Weaknesses
Table 185. MedTide Inc. Basic Information, Manufacturing Base and Competitors
Table 186. MedTide Inc. Major Business
Table 187. MedTide Inc. RNA Synthesis Product and Services
Table 188. MedTide Inc. RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 189. MedTide Inc. Recent Developments/Updates
Table 190. MedTide Inc. Competitive Strengths & Weaknesses
Table 191. Porton Pharma Solutions Basic Information, Manufacturing Base and Competitors
Table 192. Porton Pharma Solutions Major Business
Table 193. Porton Pharma Solutions RNA Synthesis Product and Services
Table 194. Porton Pharma Solutions RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 195. Porton Pharma Solutions Recent Developments/Updates
Table 196. Porton Pharma Solutions Competitive Strengths & Weaknesses
Table 197. Microsynth AG Basic Information, Manufacturing Base and Competitors
Table 198. Microsynth AG Major Business
Table 199. Microsynth AG RNA Synthesis Product and Services
Table 200. Microsynth AG RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 201. Microsynth AG Recent Developments/Updates
Table 202. Microsynth AG Competitive Strengths & Weaknesses
Table 203. Eton Bioscience Basic Information, Manufacturing Base and Competitors
Table 204. Eton Bioscience Major Business
Table 205. Eton Bioscience RNA Synthesis Product and Services
Table 206. Eton Bioscience RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 207. Eton Bioscience Recent Developments/Updates
Table 208. Eton Bioscience Competitive Strengths & Weaknesses
Table 209. Aurigene Pharmaceutical Services Basic Information, Manufacturing Base and Competitors
Table 210. Aurigene Pharmaceutical Services Major Business
Table 211. Aurigene Pharmaceutical Services RNA Synthesis Product and Services
Table 212. Aurigene Pharmaceutical Services RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 213. Aurigene Pharmaceutical Services Recent Developments/Updates
Table 214. Aurigene Pharmaceutical Services Competitive Strengths & Weaknesses
Table 215. Synbio Technologies Basic Information, Manufacturing Base and Competitors
Table 216. Synbio Technologies Major Business
Table 217. Synbio Technologies RNA Synthesis Product and Services
Table 218. Synbio Technologies RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 219. Synbio Technologies Recent Developments/Updates
Table 220. Synbio Technologies Competitive Strengths & Weaknesses
Table 221. biomers.net GmbH Basic Information, Manufacturing Base and Competitors
Table 222. biomers.net GmbH Major Business
Table 223. biomers.net GmbH RNA Synthesis Product and Services
Table 224. biomers.net GmbH RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 225. biomers.net GmbH Recent Developments/Updates
Table 226. biomers.net GmbH Competitive Strengths & Weaknesses
Table 227. Hunan Aikerui Bioengineering Basic Information, Manufacturing Base and Competitors
Table 228. Hunan Aikerui Bioengineering Major Business
Table 229. Hunan Aikerui Bioengineering RNA Synthesis Product and Services
Table 230. Hunan Aikerui Bioengineering RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 231. Hunan Aikerui Bioengineering Recent Developments/Updates
Table 232. Hunan Aikerui Bioengineering Competitive Strengths & Weaknesses
Table 233. Beijing Abace Biotechnology Basic Information, Manufacturing Base and Competitors
Table 234. Beijing Abace Biotechnology Major Business
Table 235. Beijing Abace Biotechnology RNA Synthesis Product and Services
Table 236. Beijing Abace Biotechnology RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 237. Beijing Abace Biotechnology Recent Developments/Updates
Table 238. Beijing Abace Biotechnology Competitive Strengths & Weaknesses
Table 239. Global Key Players of RNA Synthesis Upstream (Raw Materials)
Table 240. Global RNA Synthesis Typical Customers
Table 1. World RNA Synthesis Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World RNA Synthesis Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World RNA Synthesis Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World RNA Synthesis Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World RNA Synthesis Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World RNA Synthesis Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World RNA Synthesis Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World RNA Synthesis Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World RNA Synthesis Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key RNA Synthesis Players in 2025
Table 12. World RNA Synthesis Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global RNA Synthesis Company Evaluation Quadrant
Table 14. Head Office of Key RNA Synthesis Players
Table 15. RNA Synthesis Market: Company Product Type Footprint
Table 16. RNA Synthesis Market: Company Product Application Footprint
Table 17. RNA Synthesis Mergers & Acquisitions Activity
Table 18. United States VS China RNA Synthesis Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China RNA Synthesis Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based RNA Synthesis Companies, Headquarters (States, Country)
Table 21. United States Based Companies RNA Synthesis Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies RNA Synthesis Revenue Market Share (2021-2026)
Table 23. China Based RNA Synthesis Companies, Headquarters (Province, Country)
Table 24. China Based Companies RNA Synthesis Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies RNA Synthesis Revenue Market Share (2021-2026)
Table 26. Rest of World Based RNA Synthesis Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies RNA Synthesis Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies RNA Synthesis Revenue Market Share (2021-2026)
Table 29. World RNA Synthesis Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World RNA Synthesis Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World RNA Synthesis Market Size by Type (2027-2032) & (USD Million)
Table 32. World RNA Synthesis Market Size by Product Function, (USD Million), 2021 & 2025 & 2032
Table 33. World RNA Synthesis Market Size Value by Product Function (2021-2026) & (USD Million)
Table 34. World RNA Synthesis Market Size by Product Function (2027-2032) & (USD Million)
Table 35. World RNA Synthesis Market Size by Synthesis Rate, (USD Million), 2021 & 2025 & 2032
Table 36. World RNA Synthesis Market Size Value by Synthesis Rate (2021-2026) & (USD Million)
Table 37. World RNA Synthesis Market Size by Synthesis Rate (2027-2032) & (USD Million)
Table 38. World RNA Synthesis Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World RNA Synthesis Market Size by Application (2021-2026) & (USD Million)
Table 40. World RNA Synthesis Market Size by Application (2027-2032) & (USD Million)
Table 41. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 42. Thermo Fisher Scientific Major Business
Table 43. Thermo Fisher Scientific RNA Synthesis Product and Services
Table 44. Thermo Fisher Scientific RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Thermo Fisher Scientific Recent Developments/Updates
Table 46. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 47. Danaher Basic Information, Manufacturing Base and Competitors
Table 48. Danaher Major Business
Table 49. Danaher RNA Synthesis Product and Services
Table 50. Danaher RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Danaher Recent Developments/Updates
Table 52. Danaher Competitive Strengths & Weaknesses
Table 53. Merck Basic Information, Manufacturing Base and Competitors
Table 54. Merck Major Business
Table 55. Merck RNA Synthesis Product and Services
Table 56. Merck RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Merck Recent Developments/Updates
Table 58. Merck Competitive Strengths & Weaknesses
Table 59. Agilent Technologies Basic Information, Manufacturing Base and Competitors
Table 60. Agilent Technologies Major Business
Table 61. Agilent Technologies RNA Synthesis Product and Services
Table 62. Agilent Technologies RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Agilent Technologies Recent Developments/Updates
Table 64. Agilent Technologies Competitive Strengths & Weaknesses
Table 65. Nitto Denko Basic Information, Manufacturing Base and Competitors
Table 66. Nitto Denko Major Business
Table 67. Nitto Denko RNA Synthesis Product and Services
Table 68. Nitto Denko RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Nitto Denko Recent Developments/Updates
Table 70. Nitto Denko Competitive Strengths & Weaknesses
Table 71. ST Pharm Basic Information, Manufacturing Base and Competitors
Table 72. ST Pharm Major Business
Table 73. ST Pharm RNA Synthesis Product and Services
Table 74. ST Pharm RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. ST Pharm Recent Developments/Updates
Table 76. ST Pharm Competitive Strengths & Weaknesses
Table 77. WuXi AppTec Basic Information, Manufacturing Base and Competitors
Table 78. WuXi AppTec Major Business
Table 79. WuXi AppTec RNA Synthesis Product and Services
Table 80. WuXi AppTec RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. WuXi AppTec Recent Developments/Updates
Table 82. WuXi AppTec Competitive Strengths & Weaknesses
Table 83. GenScript Biotech Basic Information, Manufacturing Base and Competitors
Table 84. GenScript Biotech Major Business
Table 85. GenScript Biotech RNA Synthesis Product and Services
Table 86. GenScript Biotech RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. GenScript Biotech Recent Developments/Updates
Table 88. GenScript Biotech Competitive Strengths & Weaknesses
Table 89. TriLink Basic Information, Manufacturing Base and Competitors
Table 90. TriLink Major Business
Table 91. TriLink RNA Synthesis Product and Services
Table 92. TriLink RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. TriLink Recent Developments/Updates
Table 94. TriLink Competitive Strengths & Weaknesses
Table 95. Kaneka Basic Information, Manufacturing Base and Competitors
Table 96. Kaneka Major Business
Table 97. Kaneka RNA Synthesis Product and Services
Table 98. Kaneka RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Kaneka Recent Developments/Updates
Table 100. Kaneka Competitive Strengths & Weaknesses
Table 101. BioSpring GmbH Basic Information, Manufacturing Base and Competitors
Table 102. BioSpring GmbH Major Business
Table 103. BioSpring GmbH RNA Synthesis Product and Services
Table 104. BioSpring GmbH RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. BioSpring GmbH Recent Developments/Updates
Table 106. BioSpring GmbH Competitive Strengths & Weaknesses
Table 107. Bachem Holding AG Basic Information, Manufacturing Base and Competitors
Table 108. Bachem Holding AG Major Business
Table 109. Bachem Holding AG RNA Synthesis Product and Services
Table 110. Bachem Holding AG RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Bachem Holding AG Recent Developments/Updates
Table 112. Bachem Holding AG Competitive Strengths & Weaknesses
Table 113. Ajinomoto Bio-Pharma Services Basic Information, Manufacturing Base and Competitors
Table 114. Ajinomoto Bio-Pharma Services Major Business
Table 115. Ajinomoto Bio-Pharma Services RNA Synthesis Product and Services
Table 116. Ajinomoto Bio-Pharma Services RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Ajinomoto Bio-Pharma Services Recent Developments/Updates
Table 118. Ajinomoto Bio-Pharma Services Competitive Strengths & Weaknesses
Table 119. Eurofins Genomics Basic Information, Manufacturing Base and Competitors
Table 120. Eurofins Genomics Major Business
Table 121. Eurofins Genomics RNA Synthesis Product and Services
Table 122. Eurofins Genomics RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Eurofins Genomics Recent Developments/Updates
Table 124. Eurofins Genomics Competitive Strengths & Weaknesses
Table 125. Azenta Basic Information, Manufacturing Base and Competitors
Table 126. Azenta Major Business
Table 127. Azenta RNA Synthesis Product and Services
Table 128. Azenta RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Azenta Recent Developments/Updates
Table 130. Azenta Competitive Strengths & Weaknesses
Table 131. Revvity Basic Information, Manufacturing Base and Competitors
Table 132. Revvity Major Business
Table 133. Revvity RNA Synthesis Product and Services
Table 134. Revvity RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Revvity Recent Developments/Updates
Table 136. Revvity Competitive Strengths & Weaknesses
Table 137. LGC Biosearch Technologies Basic Information, Manufacturing Base and Competitors
Table 138. LGC Biosearch Technologies Major Business
Table 139. LGC Biosearch Technologies RNA Synthesis Product and Services
Table 140. LGC Biosearch Technologies RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. LGC Biosearch Technologies Recent Developments/Updates
Table 142. LGC Biosearch Technologies Competitive Strengths & Weaknesses
Table 143. Hongene Biotech Basic Information, Manufacturing Base and Competitors
Table 144. Hongene Biotech Major Business
Table 145. Hongene Biotech RNA Synthesis Product and Services
Table 146. Hongene Biotech RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Hongene Biotech Recent Developments/Updates
Table 148. Hongene Biotech Competitive Strengths & Weaknesses
Table 149. Aldevron Basic Information, Manufacturing Base and Competitors
Table 150. Aldevron Major Business
Table 151. Aldevron RNA Synthesis Product and Services
Table 152. Aldevron RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Aldevron Recent Developments/Updates
Table 154. Aldevron Competitive Strengths & Weaknesses
Table 155. Lonza Group Basic Information, Manufacturing Base and Competitors
Table 156. Lonza Group Major Business
Table 157. Lonza Group RNA Synthesis Product and Services
Table 158. Lonza Group RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. Lonza Group Recent Developments/Updates
Table 160. Lonza Group Competitive Strengths & Weaknesses
Table 161. Shanghai Jinsirui Vigorous Biotechnology Basic Information, Manufacturing Base and Competitors
Table 162. Shanghai Jinsirui Vigorous Biotechnology Major Business
Table 163. Shanghai Jinsirui Vigorous Biotechnology RNA Synthesis Product and Services
Table 164. Shanghai Jinsirui Vigorous Biotechnology RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. Shanghai Jinsirui Vigorous Biotechnology Recent Developments/Updates
Table 166. Shanghai Jinsirui Vigorous Biotechnology Competitive Strengths & Weaknesses
Table 167. PackGene Biotech Basic Information, Manufacturing Base and Competitors
Table 168. PackGene Biotech Major Business
Table 169. PackGene Biotech RNA Synthesis Product and Services
Table 170. PackGene Biotech RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. PackGene Biotech Recent Developments/Updates
Table 172. PackGene Biotech Competitive Strengths & Weaknesses
Table 173. Vernal Biosciences Basic Information, Manufacturing Base and Competitors
Table 174. Vernal Biosciences Major Business
Table 175. Vernal Biosciences RNA Synthesis Product and Services
Table 176. Vernal Biosciences RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. Vernal Biosciences Recent Developments/Updates
Table 178. Vernal Biosciences Competitive Strengths & Weaknesses
Table 179. Northern RNA Basic Information, Manufacturing Base and Competitors
Table 180. Northern RNA Major Business
Table 181. Northern RNA RNA Synthesis Product and Services
Table 182. Northern RNA RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. Northern RNA Recent Developments/Updates
Table 184. Northern RNA Competitive Strengths & Weaknesses
Table 185. MedTide Inc. Basic Information, Manufacturing Base and Competitors
Table 186. MedTide Inc. Major Business
Table 187. MedTide Inc. RNA Synthesis Product and Services
Table 188. MedTide Inc. RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 189. MedTide Inc. Recent Developments/Updates
Table 190. MedTide Inc. Competitive Strengths & Weaknesses
Table 191. Porton Pharma Solutions Basic Information, Manufacturing Base and Competitors
Table 192. Porton Pharma Solutions Major Business
Table 193. Porton Pharma Solutions RNA Synthesis Product and Services
Table 194. Porton Pharma Solutions RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 195. Porton Pharma Solutions Recent Developments/Updates
Table 196. Porton Pharma Solutions Competitive Strengths & Weaknesses
Table 197. Microsynth AG Basic Information, Manufacturing Base and Competitors
Table 198. Microsynth AG Major Business
Table 199. Microsynth AG RNA Synthesis Product and Services
Table 200. Microsynth AG RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 201. Microsynth AG Recent Developments/Updates
Table 202. Microsynth AG Competitive Strengths & Weaknesses
Table 203. Eton Bioscience Basic Information, Manufacturing Base and Competitors
Table 204. Eton Bioscience Major Business
Table 205. Eton Bioscience RNA Synthesis Product and Services
Table 206. Eton Bioscience RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 207. Eton Bioscience Recent Developments/Updates
Table 208. Eton Bioscience Competitive Strengths & Weaknesses
Table 209. Aurigene Pharmaceutical Services Basic Information, Manufacturing Base and Competitors
Table 210. Aurigene Pharmaceutical Services Major Business
Table 211. Aurigene Pharmaceutical Services RNA Synthesis Product and Services
Table 212. Aurigene Pharmaceutical Services RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 213. Aurigene Pharmaceutical Services Recent Developments/Updates
Table 214. Aurigene Pharmaceutical Services Competitive Strengths & Weaknesses
Table 215. Synbio Technologies Basic Information, Manufacturing Base and Competitors
Table 216. Synbio Technologies Major Business
Table 217. Synbio Technologies RNA Synthesis Product and Services
Table 218. Synbio Technologies RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 219. Synbio Technologies Recent Developments/Updates
Table 220. Synbio Technologies Competitive Strengths & Weaknesses
Table 221. biomers.net GmbH Basic Information, Manufacturing Base and Competitors
Table 222. biomers.net GmbH Major Business
Table 223. biomers.net GmbH RNA Synthesis Product and Services
Table 224. biomers.net GmbH RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 225. biomers.net GmbH Recent Developments/Updates
Table 226. biomers.net GmbH Competitive Strengths & Weaknesses
Table 227. Hunan Aikerui Bioengineering Basic Information, Manufacturing Base and Competitors
Table 228. Hunan Aikerui Bioengineering Major Business
Table 229. Hunan Aikerui Bioengineering RNA Synthesis Product and Services
Table 230. Hunan Aikerui Bioengineering RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 231. Hunan Aikerui Bioengineering Recent Developments/Updates
Table 232. Hunan Aikerui Bioengineering Competitive Strengths & Weaknesses
Table 233. Beijing Abace Biotechnology Basic Information, Manufacturing Base and Competitors
Table 234. Beijing Abace Biotechnology Major Business
Table 235. Beijing Abace Biotechnology RNA Synthesis Product and Services
Table 236. Beijing Abace Biotechnology RNA Synthesis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 237. Beijing Abace Biotechnology Recent Developments/Updates
Table 238. Beijing Abace Biotechnology Competitive Strengths & Weaknesses
Table 239. Global Key Players of RNA Synthesis Upstream (Raw Materials)
Table 240. Global RNA Synthesis Typical Customers
LIST OF FIGURES
Figure 1. RNA Synthesis Picture
Figure 2. World RNA Synthesis Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World RNA Synthesis Total Revenue (2021-2032) & (USD Million)
Figure 4. World RNA Synthesis Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World RNA Synthesis Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company RNA Synthesis Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company RNA Synthesis Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company RNA Synthesis Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company RNA Synthesis Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company RNA Synthesis Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company RNA Synthesis Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company RNA Synthesis Revenue (2021-2032) & (USD Million)
Figure 13. RNA Synthesis Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World RNA Synthesis Consumption Value (2021-2032) & (USD Million)
Figure 16. World RNA Synthesis Consumption Value Market Share by Region (2021-2032)
Figure 17. United States RNA Synthesis Consumption Value (2021-2032) & (USD Million)
Figure 18. China RNA Synthesis Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe RNA Synthesis Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan RNA Synthesis Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea RNA Synthesis Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN RNA Synthesis Consumption Value (2021-2032) & (USD Million)
Figure 23. India RNA Synthesis Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of RNA Synthesis by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for RNA Synthesis Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for RNA Synthesis Markets in 2025
Figure 27. United States VS China: RNA Synthesis Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: RNA Synthesis Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World RNA Synthesis Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World RNA Synthesis Market Size Market Share by Type in 2025
Figure 31. Transcription
Figure 32. RNA Replication
Figure 33. World RNA Synthesis Market Size Market Share by Type (2021-2032)
Figure 34. World RNA Synthesis Market Size by Product Function, (USD Million), 2021 & 2025 & 2032
Figure 35. World RNA Synthesis Market Size Market Share by Product Function in 2025
Figure 36. Coding RNA
Figure 37. Non-coding RNA
Figure 38. World RNA Synthesis Market Size Market Share by Product Function (2021-2032)
Figure 39. World RNA Synthesis Market Size by Synthesis Rate, (USD Million), 2021 & 2025 & 2032
Figure 40. World RNA Synthesis Market Size Market Share by Synthesis Rate in 2025
Figure 41. 20~40 nt/s
Figure 42. 40~100 nt/s
Figure 43. ?100 nt/s
Figure 44. World RNA Synthesis Market Size Market Share by Synthesis Rate (2021-2032)
Figure 45. World RNA Synthesis Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 46. World RNA Synthesis Market Size Market Share by Application in 2025
Figure 47. Biomedicine
Figure 48. Molecular Diagnostics
Figure 49. Agriculture
Figure 50. Other
Figure 51. World RNA Synthesis Market Size Market Share by Application (2021-2032)
Figure 52. RNA Synthesis Industrial Chain
Figure 53. Methodology
Figure 54. Research Process and Data Source
Figure 1. RNA Synthesis Picture
Figure 2. World RNA Synthesis Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World RNA Synthesis Total Revenue (2021-2032) & (USD Million)
Figure 4. World RNA Synthesis Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World RNA Synthesis Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company RNA Synthesis Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company RNA Synthesis Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company RNA Synthesis Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company RNA Synthesis Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company RNA Synthesis Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company RNA Synthesis Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company RNA Synthesis Revenue (2021-2032) & (USD Million)
Figure 13. RNA Synthesis Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World RNA Synthesis Consumption Value (2021-2032) & (USD Million)
Figure 16. World RNA Synthesis Consumption Value Market Share by Region (2021-2032)
Figure 17. United States RNA Synthesis Consumption Value (2021-2032) & (USD Million)
Figure 18. China RNA Synthesis Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe RNA Synthesis Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan RNA Synthesis Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea RNA Synthesis Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN RNA Synthesis Consumption Value (2021-2032) & (USD Million)
Figure 23. India RNA Synthesis Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of RNA Synthesis by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for RNA Synthesis Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for RNA Synthesis Markets in 2025
Figure 27. United States VS China: RNA Synthesis Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: RNA Synthesis Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World RNA Synthesis Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World RNA Synthesis Market Size Market Share by Type in 2025
Figure 31. Transcription
Figure 32. RNA Replication
Figure 33. World RNA Synthesis Market Size Market Share by Type (2021-2032)
Figure 34. World RNA Synthesis Market Size by Product Function, (USD Million), 2021 & 2025 & 2032
Figure 35. World RNA Synthesis Market Size Market Share by Product Function in 2025
Figure 36. Coding RNA
Figure 37. Non-coding RNA
Figure 38. World RNA Synthesis Market Size Market Share by Product Function (2021-2032)
Figure 39. World RNA Synthesis Market Size by Synthesis Rate, (USD Million), 2021 & 2025 & 2032
Figure 40. World RNA Synthesis Market Size Market Share by Synthesis Rate in 2025
Figure 41. 20~40 nt/s
Figure 42. 40~100 nt/s
Figure 43. ?100 nt/s
Figure 44. World RNA Synthesis Market Size Market Share by Synthesis Rate (2021-2032)
Figure 45. World RNA Synthesis Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 46. World RNA Synthesis Market Size Market Share by Application in 2025
Figure 47. Biomedicine
Figure 48. Molecular Diagnostics
Figure 49. Agriculture
Figure 50. Other
Figure 51. World RNA Synthesis Market Size Market Share by Application (2021-2032)
Figure 52. RNA Synthesis Industrial Chain
Figure 53. Methodology
Figure 54. Research Process and Data Source
